MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Relationship between Insulin-like Growth Factor-1 and characteristics of physical activity in patients with Parkinson’s disease

K. Nagaki, M. Ikenaga, S. Fujioka, Y. Tsuboi (fukuoka, Japan)

Meeting: 2017 International Congress

Abstract Number: 991

Keywords: Cognitive dysfunction, Neuroprotective agents, Rehabilitation

Session Information

Date: Wednesday, June 7, 2017

Session Title: Parkinson's Disease: Cognition

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To clarify the characteristics of decreased physical activity and relationship between physical activity intensity and Insulin-like Growth Factor-1 (IGF-1) in patients with Parkinson’s disease (PD). 

Background: IGF-1 is a neuro-protect substance and may prevent cognitive decline. Muscle activity is known to accelerate secretion of IGF-1; however, little has been known about the role of IGF-1 in PD patients.

Methods: This study included 35 PD patients (Hoehn & Yahr: 1 to 4) who visited Fukuoka University Hospital from July 2015 to October 2015. The amount of physical activity was calculated by using a 3-axis accelerometer, and an average of daily Moderate-to-Vigorous Physical Activity (MVPA) and Low Physical Activity (LPA) was calculated. Blood sample was collected for measurement of serum IGF-1. The physical activity intensity was compared with the control group (n=70), and then the correlation analysis of the physical activity intensity and the serum IGF-1 was carried out.

Results: Compared with the control group, both MVPA (p<0.001) and LPA (p<0.001) were lower in PD patients. In PD patients, there was correlation between IGF-1 and MVPA (over 3.5METs) (Spearman’s rank correlation coefficient:p=0.033). however, no correlation was seen with LPA.

Conclusions: Lower physical activity intensity might be caused by slowness of movement and inactive living patterns of PD patients. Lower MVPA seems to be correlated with lower serum IGF-1, indicating that exercise for higher activity intensity inducing higher IGF-1 may slow the disease progression due to its neuroprotective effect in PD patients.

To cite this abstract in AMA style:

K. Nagaki, M. Ikenaga, S. Fujioka, Y. Tsuboi. Relationship between Insulin-like Growth Factor-1 and characteristics of physical activity in patients with Parkinson’s disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/relationship-between-insulin-like-growth-factor-1-and-characteristics-of-physical-activity-in-patients-with-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/relationship-between-insulin-like-growth-factor-1-and-characteristics-of-physical-activity-in-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley